Acuitas Therapeutics collaborates on mRNA-LNP prime editing study for genetic liver disease
Read about Acuitas Therapeutics collaborates on mRNA-LNP prime editing study for genetic liver disease
Acuitas Therapeutics showcases collaboration with Children’s Hospital of Philadelphia for personalized CRISPR therapy and new LNP research at ASGCT 2025
Read about Acuitas Therapeutics showcases collaboration with Children’s Hospital of Philadelphia for personalized CRISPR therapy and new LNP research at ASGCT 2025
Acuitas Therapeutics demonstrates enhanced mRNA-LNP activity in cancer and viral vaccine development
Read about Acuitas Therapeutics demonstrates enhanced mRNA-LNP activity in cancer and viral vaccine development
Acuitas to present data on latest LNP safety and activity profiles at ASGCT 2025
Read about Acuitas to present data on latest LNP safety and activity profiles at ASGCT 2025
Acuitas Therapeutics named one of Canada’s Top Small & Medium Employers of 2025
Read about Acuitas Therapeutics named one of Canada’s Top Small & Medium Employers of 2025
Acuitas awarded as one of Canada’s Most Admired™ Corporate Cultures for 2024
Read about Acuitas awarded as one of Canada’s Most Admired™ Corporate Cultures for 2024
PUBLICATION ALERT: Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection
Read about PUBLICATION ALERT: Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection
PUBLICATION ALERT: Monitoring mRNA vaccine antigen expression in vivo using PET/CT
Read about PUBLICATION ALERT: Monitoring mRNA vaccine antigen expression in vivo using PET/CT
PUBLICATION ALERT: iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA
Read about PUBLICATION ALERT: iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA
Acuitas Therapeutics named one of BC’s Top Employers of 2025
Read about Acuitas Therapeutics named one of BC’s Top Employers of 2025
PUBLICATION ALERT: High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays
Read about PUBLICATION ALERT: High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays